Skip to main content
NVDA+0.14%AAPL+0.02%GOOGL-0.63%MSFT-0.03%AMZN+0.24%TSM-3.01%SPCX-4.19%META-0.23%AVGO-4.35%TSLA-0.03%SKHY-4.35%MU+0.17%BRK-B+0.95%LLY-1.61%AMD-3.90%JPM+0.56%WMT+2.22%ASMLa+1.27%V+0.81%XOM+2.75%JNJ-0.76%INTC-5.34%MA+0.82%0700.HK+2.65%ABBV+0.39%CSCO-2.13%1398.HK-0.43%CVX+3.12%COST+0.60%AP2d-0.09%AMAT-2.13%LRCX-2.71%ORCL-5.48%DELL-0.76%BAC+0.17%KO+2.27%CAT-2.17%PG+1.87%1816.HK-26.81%UNH-1.34%3988.HK+1.70%0005.HK+1.85%GE+0.66%HSBA.L-1.95%PM+4.05%0857.HK-0.81%0939.HK+1.16%NFLX+2.68%MS-1.20%HD+3.39%AUDCHF+0.68%AUDJPY+0.59%EURAUD-0.58%CADCHF+0.49%EURCAD-0.48%CADJPY+0.44%USDTRY+0.44%USDZAR-0.42%GBPTRY+0.41%GBPAUD-0.40%AUDUSD+0.38%NZDCHF+0.36%EURNZD-0.34%GBPZAR-0.32%GBPHKD+0.32%NZDJPY+0.31%PLNJPY+0.31%NOKJPY+0.30%GBPMXN-0.28%USDCAD-0.28%EURZAR-0.26%GBPCAD-0.25%SGDJPY+0.24%AUDNZD+0.24%GBPCHF+0.23%NZDSGD+0.23%AUDSGD+0.23%EURGBP-0.22%USDCHF+0.22%EURUSD-0.20%USDSEK-0.18%USDJPY+0.17%GBPJPY+0.17%NZDMXN+0.17%USDNOK-0.16%USDDKK-0.16%USDPLN-0.16%AUDNOK+0.16%USDILS+0.16%USDMXN-0.16%AUDDKK+0.16%EURHKD+0.15%NZDUSD+0.14%NZDCAD-0.13%GBPNZD-0.12%USDCNH-0.11%USDSGD-0.10%AUDCAD+0.09%EURCNH+0.07%USDTHB-0.06%EURSGD+0.06%EURJPY-0.06%CHFJPY-0.05%CHFSGD+0.04%USDCOP-0.04%CHFSEK-0.04%CHFNOK-0.03%EURSEK-0.02%GBPUSD+0.02%EURCZK+0.02%EURNOK-0.01%EURPLN-0.01%EURDKK-0.01%GBPSGD+0.01%USDHKD0.00%EURCHF0.00%XPTUSD+2.21%XAGUSD+1.89%GAGUSD+1.89%HG1+1.46%XAUUSD+1.30%GAUUSD+1.30%UKOIL-1.10%USOIL-0.99%S1+0.76%COTTON+0.73%W1+0.46%C1+0.45%BTCUSD-1.12%ETHUSD+11.79%USDTUSD-0.04%XRPUSD+5.55%SOLUSD+1.82%TRXUSDT-1.00%ZECUSDT-7.98%DOGEUSD+5.25%XMRUSDT-3.00%LINKUSD+7.35%XLMUSD-2.86%BCHUSDT-6.59%LTCUSD+1.20%UNIUSD-6.86%SUIUSD-5.92%HBARUSDT-1.02%TONUSD+18.86%TAOUSDT-5.94%AAVEUSD-4.57%DOTUSDT+3.36%ICPUSDT-6.42%ONDOUSDT+1.96%WLDUSDT-5.23%JUPUSDT-0.32%ARBUSDT-4.22%ATOMUSDT+8.78%STXUSDT+5.34%INJUSDT-6.68%FETUSDT-3.62%PYTHUSDT+11.79%TIAUSDT+11.43%SEIUSDT-3.41%IMXUSDT+5.69%GRTUSDT-3.25%OPUSDT-0.41%IOTAUSDT-5.34%WIFUSDT-7.85%AXSUSDT-5.63%POLUSDT-2.39%FARTCOINUSDT+1.90%EOSUSDT+0.64%DYDXUSDT+0.28%GALAUSDT-3.84%ORDIUSDT-5.54%RONINUSDT-2.67%NOTUSDT-3.68%NVDA+0.14%AAPL+0.02%GOOGL-0.63%MSFT-0.03%AMZN+0.24%TSM-3.01%SPCX-4.19%META-0.23%AVGO-4.35%TSLA-0.03%SKHY-4.35%MU+0.17%BRK-B+0.95%LLY-1.61%AMD-3.90%JPM+0.56%WMT+2.22%ASMLa+1.27%V+0.81%XOM+2.75%JNJ-0.76%INTC-5.34%MA+0.82%0700.HK+2.65%ABBV+0.39%CSCO-2.13%1398.HK-0.43%CVX+3.12%COST+0.60%AP2d-0.09%AMAT-2.13%LRCX-2.71%ORCL-5.48%DELL-0.76%BAC+0.17%KO+2.27%CAT-2.17%PG+1.87%1816.HK-26.81%UNH-1.34%3988.HK+1.70%0005.HK+1.85%GE+0.66%HSBA.L-1.95%PM+4.05%0857.HK-0.81%0939.HK+1.16%NFLX+2.68%MS-1.20%HD+3.39%AUDCHF+0.68%AUDJPY+0.59%EURAUD-0.58%CADCHF+0.49%EURCAD-0.48%CADJPY+0.44%USDTRY+0.44%USDZAR-0.42%GBPTRY+0.41%GBPAUD-0.40%AUDUSD+0.38%NZDCHF+0.36%EURNZD-0.34%GBPZAR-0.32%GBPHKD+0.32%NZDJPY+0.31%PLNJPY+0.31%NOKJPY+0.30%GBPMXN-0.28%USDCAD-0.28%EURZAR-0.26%GBPCAD-0.25%SGDJPY+0.24%AUDNZD+0.24%GBPCHF+0.23%NZDSGD+0.23%AUDSGD+0.23%EURGBP-0.22%USDCHF+0.22%EURUSD-0.20%USDSEK-0.18%USDJPY+0.17%GBPJPY+0.17%NZDMXN+0.17%USDNOK-0.16%USDDKK-0.16%USDPLN-0.16%AUDNOK+0.16%USDILS+0.16%USDMXN-0.16%AUDDKK+0.16%EURHKD+0.15%NZDUSD+0.14%NZDCAD-0.13%GBPNZD-0.12%USDCNH-0.11%USDSGD-0.10%AUDCAD+0.09%EURCNH+0.07%USDTHB-0.06%EURSGD+0.06%EURJPY-0.06%CHFJPY-0.05%CHFSGD+0.04%USDCOP-0.04%CHFSEK-0.04%CHFNOK-0.03%EURSEK-0.02%GBPUSD+0.02%EURCZK+0.02%EURNOK-0.01%EURPLN-0.01%EURDKK-0.01%GBPSGD+0.01%USDHKD0.00%EURCHF0.00%XPTUSD+2.21%XAGUSD+1.89%GAGUSD+1.89%HG1+1.46%XAUUSD+1.30%GAUUSD+1.30%UKOIL-1.10%USOIL-0.99%S1+0.76%COTTON+0.73%W1+0.46%C1+0.45%BTCUSD-1.12%ETHUSD+11.79%USDTUSD-0.04%XRPUSD+5.55%SOLUSD+1.82%TRXUSDT-1.00%ZECUSDT-7.98%DOGEUSD+5.25%XMRUSDT-3.00%LINKUSD+7.35%XLMUSD-2.86%BCHUSDT-6.59%LTCUSD+1.20%UNIUSD-6.86%SUIUSD-5.92%HBARUSDT-1.02%TONUSD+18.86%TAOUSDT-5.94%AAVEUSD-4.57%DOTUSDT+3.36%ICPUSDT-6.42%ONDOUSDT+1.96%WLDUSDT-5.23%JUPUSDT-0.32%ARBUSDT-4.22%ATOMUSDT+8.78%STXUSDT+5.34%INJUSDT-6.68%FETUSDT-3.62%PYTHUSDT+11.79%TIAUSDT+11.43%SEIUSDT-3.41%IMXUSDT+5.69%GRTUSDT-3.25%OPUSDT-0.41%IOTAUSDT-5.34%WIFUSDT-7.85%AXSUSDT-5.63%POLUSDT-2.39%FARTCOINUSDT+1.90%EOSUSDT+0.64%DYDXUSDT+0.28%GALAUSDT-3.84%ORDIUSDT-5.54%RONINUSDT-2.67%NOTUSDT-3.68%
CT

CRISPR Therapeutics AG (CRSP)

NASDAQ • Healthcare

$50.44
-$1.91 (-3.6%)
Market closed

Last close at October 8, 2026 at 20:00 UTC

Open$51.51
Day Range$50.06 - $53.5
Avg. Volume (3M)1.8M
Market Cap$4.8B
52 Week Range
$44.12$78
Next EarningsIn 31 daysNov 9, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$13.3M
Net Income (TTM)
-$451.1M
EPS (TTM)
-$4.76
ROA (TTM)
-17.02%
Current Ratio
17.85

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-19.1%Q1 2026-$1.37
-7.6%Q2 2026-$1.28
+21.0%Q3 2026-$0.94
Next

Nov 9

in 31 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +21.0%

CRISPR Therapeutics beat expectations on earnings in the second fiscal quarter of 2026, reported August 3, as EPS of -$0.94 topped the -$1.19 estimate (+21.0%) and improved from -$2.40 a year ago. Net income was a loss of roughly $91.2 million, improving +56% year over year from a loss of about $208.5 million, while operating income came in at a loss of about $114.8 million. Cash flow remained negative, with negative operating cash flow of roughly $192.4 million during the quarter. For the next period, consensus calls for EPS of $-1.06 on revenue of $14.8 million.

View full earnings history

About CRISPR Therapeutics AG

CRISPR Therapeutics AG (NASDAQ: CRSP) is a biotechnology company focused on gene-edited medicines. In qualitative terms it is a clinical-stage healthcare business built around CRISPR/Cas9, which it uses to alter genetic code, with programs spanning ex vivo therapies, allogeneic CAR-T candidates, and stem cell-derived approaches.

Name
CRISPR Therapeutics AG
CEO
Samarth Kulkarni
Website
www.crisprtx.com
Industry
Healthcare
Year Founded
2013
Employees
393

Today's Snapshot

AI-generated

CRSP closed 3.6% lower on heavier trading than usual. CRISPR Therapeutics announced that clinical data on CTX310, an experimental gene-editing treatment, will be presented at a heart meeting.

Trading Volume

Above 10d avg 1.6M

2.8M

vs S&P 500 Today

Strong Underperformance

-3.11%

Updated: October 8, 2026 at 20:29 UTC

CRSP Headlines

Fresh Valuation Checks Across Key Stocks

April 4, 2026

6 min read

Biotech ETFs Flash Classic Reversal Signal

April 1, 2026

2 min read
View All News

Technical Indicators

1 Buy1 Neutral6 Sell
CRSP is trading near 50.44 and presents a weakening technical profile, with momentum indicators tilted toward downside while trend strength remains muted. The MACD is negative and the CCI is deeply below zero, while the RSI sits under neutral, pointing to fading momentum; meanwhile the ADX near 19 signals little trending conviction. Price is trading below short- and medium-term moving averages as well as the 200-day level, and ATR shows elevated volatility. On-balance volume is negative, reinforcing distribution. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$54.08 - $54.68
    Sell
  • RSI (14)38.00
    Neutral
  • Stochastic %K (14, 3, 3)6.31
    Buy
  • MACD Level (12, 26)-0.49
    Sell

Peers & Related Assets

BEAMBeam Therapeutics Inc.
$24.6-0.7%
NTLAIntellia Therapeutics, Inc.
$12.6+7.6%
EDITEditas Medicine, Inc.
$2.84+3.3%
RGNXREGENXBIO Inc.
$8.09+6.5%
DNAGinkgo Bioworks Holdings, Inc.
DTILPrecision BioSciences, Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.